Literature DB >> 26329388

Clinical and genetic features of dyskeratosis congenita, cryptic dyskeratosis congenita, and Hoyeraal-Hreidarsson syndrome in Japan.

Hiroki Yamaguchi1, Hirotoshi Sakaguchi2, Kenichi Yoshida3, Miharu Yabe4, Hiromasa Yabe4, Yusuke Okuno2, Hideki Muramatsu2, Yoshiyuki Takahashi2, Shunsuke Yui5, Yuichi Shiraishi6, Kenichi Chiba6, Hiroko Tanaka7, Satoru Miyano6,7, Koiti Inokuchi5, Etsuro Ito8, Seishi Ogawa3, Seiji Kojima2.   

Abstract

Dyskeratosis congenita (DKC) is an inherited bone marrow failure (BMF) syndrome typified by reticulated skin pigmentation, nail dystrophy, and mucosal leukoplakia. Hoyeraal-Hreidarsson syndrome (HHS) is considered to be a severe form of DKC. Unconventional forms of DKC, which develop slowly in adulthood but without the physical anomalies characteristic of DKC (cryptic DKC), have been reported. Clinical and genetic features of DKC have been investigated in Caucasian, Black, and Hispanic populations, but not in Asian populations. The present study aimed to determine the clinical and genetic features of DKC, HHS, and cryptic DKC among Japanese patients. We analyzed 16 patients diagnosed with DKC, three patients with HHS, and 15 patients with cryptic DKC. We found that platelet count was significantly more depressed than neutrophil count or hemoglobin value in DKC patients, and identified DKC patients with large deletions in the telomerase reverse transcriptase and cryptic DKC patients with RTEL1 mutations on both alleles. This led to some patients previously considered to have unclassifiable BMF being diagnosed with cDKC through identification of new gene mutations. It thus seems important from a clinical viewpoint to re-examine the clinical characteristics, frequency of genetic mutations, and treatment efficacy in DKC, HHS, and cDKC.

Entities:  

Keywords:  Bone marrow failure; Cryptic dyskeratosis congenita; Dyskeratosis congenita; Genetic feature; Hoyeraal-Hreidarsson syndrome

Mesh:

Substances:

Year:  2015        PMID: 26329388     DOI: 10.1007/s12185-015-1861-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  28 in total

1.  Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.

Authors:  Hiroki Yamaguchi; Gabriela M Baerlocher; Peter M Lansdorp; Stephen J Chanock; Olga Nunez; Elaine Sloand; Neal S Young
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

2.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.

Authors:  N S Heiss; S W Knight; T J Vulliamy; S M Klauck; S Wiemann; P J Mason; A Poustka; I Dokal
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

Review 3.  Inherited bone marrow failure syndromes in 2012.

Authors:  Hirotoshi Sakaguchi; Koji Nakanishi; Seiji Kojima
Journal:  Int J Hematol       Date:  2012-12-28       Impact factor: 2.490

4.  Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability.

Authors:  Tangui Le Guen; Laurent Jullien; Fabien Touzot; Michael Schertzer; Laetitia Gaillard; Mylène Perderiset; Wassila Carpentier; Patrick Nitschke; Capucine Picard; Gérard Couillault; Jean Soulier; Alain Fischer; Isabelle Callebaut; Nada Jabado; Arturo Londono-Vallejo; Jean-Pierre de Villartay; Patrick Revy
Journal:  Hum Mol Genet       Date:  2013-04-15       Impact factor: 6.150

5.  Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.

Authors:  Patrick F Fogarty; Hiroki Yamaguchi; Adrian Wiestner; Gabriela M Baerlocher; Elaine Sloand; Weihua S Zeng; Elizabeth J Read; Peter M Lansdorp; Neal S Young
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

6.  Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.

Authors:  Tom Vulliamy; Richard Beswick; Michael Kirwan; Anna Marrone; Martin Digweed; Amanda Walne; Inderjeet Dokal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

7.  Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.

Authors:  Anna Marrone; Amanda Walne; Hannah Tamary; Yuka Masunari; Michael Kirwan; Richard Beswick; Tom Vulliamy; Inderjeet Dokal
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

Review 8.  Advances in the understanding of dyskeratosis congenita.

Authors:  Amanda J Walne; Inderjeet Dokal
Journal:  Br J Haematol       Date:  2009-02-04       Impact factor: 6.998

9.  Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.

Authors:  Davide Ruggero; Silvia Grisendi; Francesco Piazza; Eduardo Rego; Francesca Mari; Pulivarthi H Rao; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

Review 10.  Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Bari J Ballew; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2013-06       Impact factor: 2.929

View more
  10 in total

1.  Regulation of human telomerase RNA biogenesis and localization.

Authors:  Jian Qin; Chantal Autexier
Journal:  RNA Biol       Date:  2020-09-02       Impact factor: 4.652

Review 2.  Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes.

Authors:  Hirotoshi Sakaguchi; Nao Yoshida
Journal:  Int J Hematol       Date:  2022-05-28       Impact factor: 2.490

3.  A Case of Presumed Dyskeratosis Congenita Causing Severe Retinal Vascular Occlusion.

Authors:  Takahisa Hirokawa; Shou Oosuka; Masahiro Tonari; Hiroshi Mizuno; Teruyo Kida; Akiko Inoue; Akira Ashida; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2021-05-07

Review 4.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819

5.  Clinical and Molecular Heterogeneity of RTEL1 Deficiency.

Authors:  Carsten Speckmann; Sushree Sangita Sahoo; Marta Rizzi; Shinsuke Hirabayashi; Axel Karow; Nina Kathrin Serwas; Marc Hoemberg; Natalja Damatova; Detlev Schindler; Jean-Baptiste Vannier; Simon J Boulton; Ulrich Pannicke; Gudrun Göhring; Kathrin Thomay; J J Verdu-Amoros; Holger Hauch; Wilhelm Woessmann; Gabriele Escherich; Eckart Laack; Liliana Rindle; Maximilian Seidl; Anne Rensing-Ehl; Ekkehart Lausch; Christine Jandrasits; Brigitte Strahm; Klaus Schwarz; Stephan R Ehl; Charlotte Niemeyer; Kaan Boztug; Marcin W Wlodarski
Journal:  Front Immunol       Date:  2017-05-01       Impact factor: 7.561

6.  Clinical heterogeneity in a family with DKC1 mutation, dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome in first cousins.

Authors:  Cristina Olivieri; Anna Mondino; Matteo Chinello; Alessandra Risso; Enrico Finale; Marina Lanciotti; Andrea Guala
Journal:  Pediatr Rep       Date:  2017-10-06

7.  TERC promotes cellular inflammatory response independent of telomerase.

Authors:  Haiying Liu; Yiding Yang; Yuanlong Ge; Juanhong Liu; Yong Zhao
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

8.  Case Report: A Missense Mutation in Dyskeratosis Congenita 1 Leads to a Benign Form of Dyskeratosis Congenita Syndrome With the Mucocutaneous Triad.

Authors:  Liqing Wang; Jianwei Li; Qiuhong Xiong; Yong-An Zhou; Ping Li; Changxin Wu
Journal:  Front Pediatr       Date:  2022-04-06       Impact factor: 3.418

9.  [Using target next-generation sequencing assay in diagnosing of 46 patients with suspected congenital anemias].

Authors:  Y Li; G X Peng; Q Y Gao; Y Li; L Ye; J P Li; L Song; H H Fan; Y Yang; Y Z Xiong; Z J Wu; W R Yang; K Zhou; X Zhao; L P Jing; F K Zhang; L Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-05-14

10.  PRDM8 reveals aberrant DNA methylation in aging syndromes and is relevant for hematopoietic and neuronal differentiation.

Authors:  Olivia Cypris; Monika Eipel; Julia Franzen; Corinna Rösseler; Vithurithra Tharmapalan; Chao-Chung Kuo; Margherita Vieri; Miloš Nikolić; Martin Kirschner; Tim H Brümmendorf; Martin Zenke; Angelika Lampert; Fabian Beier; Wolfgang Wagner
Journal:  Clin Epigenetics       Date:  2020-08-20       Impact factor: 6.551

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.